Bayer predicts mid-single digit EBITDA rise in 2017

FRANKFURT, Feb 22 (Reuters) - Bayer, the German

drugmaker that is buying U.S. seed maker Monsanto, said

it expected a mid-single digit percentage increase in adjusted

core earnings for 2017, helped by fast growing revenues from

stroke prevention pill Xarelto.

Read more